Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Brem

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
Molecular Cancer Therapeutics|July 2, 2020
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal CarcinomaSakibul Huq, Joshua Casaos, Riccardo Serra, et al.
Journal of Neurosurgery|August 13, 2021
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastomaRavi Medikonda, John Choi, Ayush Pant, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasJing Zeng, Alfred P See, Jillian Phallen, et al.
Proceedings of Spie--The International Society for Optical Engineering|March 30, 2022
Minimizing cotton retention in neurosurgical procedures: which imaging modality can help?Raphael Bechtold, Niki Tselepidakis, Benjamin Garlow, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Oncoimmunology|December 8, 2018
Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous systemRussell Maxwell, Andrew S Luksik, Tomas Garzon-Muvdi, et al.
Neurosurgery|July 15, 2024
Genomic Alterations in Molecularly Defined OligodendrogliomasCarly Weber-Levine, Maureen Rakovec, Kelly Jiang, et al.
Journal of Neuro-Oncology|October 9, 2024
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZJordina Rincon-Torroella, Maureen Rakovec, Anita L Kalluri, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
Molecular Cancer Therapeutics|July 2, 2020
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal CarcinomaSakibul Huq, Joshua Casaos, Riccardo Serra, et al.
Journal of Neurosurgery|August 13, 2021
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastomaRavi Medikonda, John Choi, Ayush Pant, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasJing Zeng, Alfred P See, Jillian Phallen, et al.
Proceedings of Spie--The International Society for Optical Engineering|March 30, 2022
Minimizing cotton retention in neurosurgical procedures: which imaging modality can help?Raphael Bechtold, Niki Tselepidakis, Benjamin Garlow, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Oncoimmunology|December 8, 2018
Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous systemRussell Maxwell, Andrew S Luksik, Tomas Garzon-Muvdi, et al.
Neurosurgery|July 15, 2024
Genomic Alterations in Molecularly Defined OligodendrogliomasCarly Weber-Levine, Maureen Rakovec, Kelly Jiang, et al.
Journal of Neuro-Oncology|October 9, 2024
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZJordina Rincon-Torroella, Maureen Rakovec, Anita L Kalluri, et al.
Pageof 30